USA – Experts, FDA officials discuss future of clinical trials
Year: 2024
Type: other
Abstract: Officials from the US Food and Drug Administration (FDA) and participants from the JAMA Summit on clinical trials recently highlighted the relationship between the randomized controlled trial (RCT), the downsides of RCTs, and the gap that exists in implementing trial results in clinical practice. The paper, published as a special communication in JAMA, was a key focus of the first JAMA Summit, a two-day meeting where stakeholders discussed how to better integrate clinical trials with clinica...
Source: OpenEdition (OpenEdition)
DOI: 10.58079/12j9x
Author: Vroby
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W6918004354
Cites:
Cited by:
Related to: